| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C5DT00576K |
| P698 | PubMed publication ID | 25999035 |
| P50 | author | Zsolt Baranyai | Q42864868 |
| Hans-Jürgen Wester | Q128303541 | ||
| P2093 | author name string | Imre Tóth | |
| Johannes Notni | |||
| Adrienn Vágner | |||
| Martina Weineisen | |||
| Dominik Reich | |||
| P2860 | cites work | Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer | Q24542039 |
| A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes | Q28219495 | ||
| Structural and functional photoacoustic molecular tomography aided by emerging contrast agents | Q30402942 | ||
| PET/MRI: challenges, solutions and perspectives | Q30559454 | ||
| Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging. | Q30718053 | ||
| Dissociation kinetics of Mn2+ complexes of NOTA and DOTA. | Q33805938 | ||
| Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease | Q33870879 | ||
| Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 | ||
| Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects | Q34327484 | ||
| PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides | Q34420335 | ||
| Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer | Q35645376 | ||
| PET imaging with ⁸⁹Zr: from radiochemistry to the clinic | Q36454584 | ||
| (S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics | Q37395793 | ||
| Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging | Q37955684 | ||
| Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery. | Q37973094 | ||
| Feasibility and availability of ⁶⁸Ga-labelled peptides. | Q37990396 | ||
| Automation synthesis modules review | Q38053661 | ||
| The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging | Q38080002 | ||
| Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. | Q38106898 | ||
| Small animal fluorescence and bioluminescence tomography: a review of approaches, algorithms and technology update | Q38170975 | ||
| Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications | Q38202090 | ||
| Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency | Q38369824 | ||
| Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). | Q39011647 | ||
| Synthesis and evaluation of diastereoisomers of 1,4,7-triazacyclononane-1,4,7-tris-(glutaric acid) (NOTGA) for multimeric radiopharmaceuticals of gallium | Q39264303 | ||
| (68)Ga small peptide imaging: comparison of NOTA and PCTA. | Q39266092 | ||
| 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process | Q39374776 | ||
| Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. | Q39605627 | ||
| First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses | Q39624760 | ||
| Multimerization of cRGD Peptides by Click Chemistry: Synthetic Strategies, Chemical Limitations, and Influence on Biological Properties | Q39657710 | ||
| Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand | Q39861818 | ||
| Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer | Q41582278 | ||
| Bone-seeking TRAP conjugates: surprising observations and their implications on the development of gallium-68-labeled bisphosphonates. | Q42159954 | ||
| A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 | ||
| Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. | Q42837828 | ||
| Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration | Q42854505 | ||
| Structural study of Ga(III), In(III), and Fe(III) complexes of triaza-macrocycle based ligands with N3S3 donor set. | Q43641550 | ||
| NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors | Q43992775 | ||
| Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation | Q44457063 | ||
| Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides | Q46884288 | ||
| Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours? | Q53211169 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | click chemistry | Q912270 |
| P304 | page(s) | 11137-11146 | |
| P577 | publication date | 2015-05-22 | |
| P1433 | published in | Dalton Transactions | Q282900 |
| P1476 | title | A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform | |
| P478 | volume | 44 |
| Q36939199 | A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway. |
| Q38873357 | A Practical Guide on the Synthesis of Metal Chelates for Molecular Imaging and Therapy by Means of Click Chemistry |
| Q38729041 | Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc. |
| Q48248853 | Dendritic poly-chelator frameworks for multimeric bioconjugation |
| Q38612027 | Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy |
| Q55261086 | Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling. |
| Q59265269 | Harnessing the Coordination Chemistry of 1,4,7-Triazacyclononane for Biomimicry and Radiopharmaceutical Applications |
| Q26799439 | Prostate-specific membrane antigen as a target for cancer imaging and therapy |
| Q38755295 | Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? |
| Q47588415 | Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals. |
| Q55258405 | Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry. |
| Q37731332 | Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors |
| Q90334696 | Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6 |
| Q92988466 | Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting |
Search more.